Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy

被引:471
作者
Chonghaile, Triona Ni [1 ]
Sarosiek, Kristopher A. [1 ]
Thanh-Trang Vo [1 ,4 ]
Ryan, Jeremy A. [1 ]
Tammareddi, Anupama [1 ]
Moore, Victoria Del Gaizo [2 ]
Deng, Jing [1 ]
Anderson, Kenneth C. [1 ]
Richardson, Paul [1 ]
Tai, Yu-Tzu [1 ]
Mitsiades, Constantine S. [1 ]
Matulonis, Ursula A. [1 ]
Drapkin, Ronny [1 ,5 ]
Stone, Richard [1 ]
DeAngelo, Daniel J. [1 ]
McConkey, David J. [3 ]
Sallan, Stephen E. [6 ]
Silverman, Lewis [6 ]
Hirsch, Michelle S. [5 ]
Carrasco, Daniel Ruben [1 ]
Letai, Anthony [1 ]
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA
[2] Elon Univ, Dept Chem, Elon, NC 27244 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
[4] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[6] Childrens Hosp Boston, Dana Farber Canc Inst, Dept Pediat Hematol Oncol, Boston, MA 02215 USA
关键词
CHRONIC LYMPHOCYTIC-LEUKEMIA; MULTIPLE-MYELOMA CELLS; IN-VIVO; APOPTOSIS; PROLIFERATION; INHIBITOR; PROTEINS; THERAPY; DEATH; LENALIDOMIDE;
D O I
10.1126/science.1206727
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cytotoxic chemotherapy targets elements common to all nucleated human cells, such as DNA and microtubules, yet it selectively kills tumor cells. Here we show that clinical response to these drugs correlates with, and may be partially governed by, the pretreatment proximity of tumor cell mitochondria to the apoptotic threshold, a property called mitochondrial priming. We used BH3 profiling to measure priming in tumor cells from patients with multiple myeloma, acute myelogenous and lymphoblastic leukemia, and ovarian cancer. This assay measures mitochondrial response to peptides derived from proapoptotic BH3 domains of proteins critical for death signaling to mitochondria. Patients with highly primed cancers exhibited superior clinical response to chemotherapy. In contrast, chemoresistant cancers and normal tissues were poorly primed. Manipulation of mitochondrial priming might enhance the efficacy of cytotoxic agents.
引用
收藏
页码:1129 / 1133
页数:6
相关论文
共 32 条
[1]   Lenalidomide and thalidomide: Mechanisms of action - Similarities and differences [J].
Anderson, KC .
SEMINARS IN HEMATOLOGY, 2005, 42 (04) :S3-S8
[2]   Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia:: High response rate and disease eradication [J].
Bosch, Francesc ;
Ferrer, Ana ;
Villamor, Neus ;
Gonzalez, Marcos ;
Briones, Javier ;
Gonzalez-Barca, Eva ;
Abella, Eugenia ;
Gardella, Santiago ;
Escoda, Lourdes ;
Perez-Ceballos, Elena ;
Asensi, Antoni ;
Jose Sayas, Ma ;
Font, Llorenc ;
Altes, Albert ;
Muntanola, Ana ;
Bertazzoni, Paola ;
Rozman, Maria ;
Aymerich, Marta ;
Gine, Eva ;
Montserrat, Ernili .
CLINICAL CANCER RESEARCH, 2008, 14 (01) :155-161
[3]   MCL-1-dependent leukemia cells are more sensitive to chemotherapy than BCL-2-dependent counterparts [J].
Brunelle, Joslyn K. ;
Ryan, Jeremy ;
Yecies, Derek ;
Opferman, Joseph T. ;
Letai, Anthony .
JOURNAL OF CELL BIOLOGY, 2009, 187 (03) :429-442
[4]   Therapeutic Advances in Acute Myeloid Leukemia [J].
Burnett, Alan ;
Wetzler, Meir ;
Loewenberg, Bob .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (05) :487-494
[5]   Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members [J].
Certo, Michael ;
Moore, Victoria Del Gaizo ;
Nishino, Mari ;
Wei, Guo ;
Korsmeyer, Stanley ;
Armstrong, Scott A. ;
Letai, Anthony .
CANCER CELL, 2006, 9 (05) :351-365
[6]   Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism [J].
Chauhan, D ;
Pandey, P ;
Ogata, A ;
Teoh, G ;
Treon, S ;
Urashima, M ;
Kharbanda, S ;
Anderson, KC .
ONCOGENE, 1997, 15 (07) :837-843
[7]   Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myeloma [J].
Chauhan, Dharminder ;
Singh, Ajita V. ;
Ciccarelli, Bryan ;
Richardson, Paul G. ;
Palladino, Michael A. ;
Anderson, Kenneth C. .
BLOOD, 2010, 115 (04) :834-845
[8]   Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function [J].
Chen, L ;
Willis, SN ;
Wei, A ;
Smith, BJ ;
Fletcher, JI ;
Hinds, MG ;
Colman, PM ;
Day, CL ;
Adams, JM ;
Huang, DCS .
MOLECULAR CELL, 2005, 17 (03) :393-403
[9]   The BCL-2 Family Reunion [J].
Chipuk, Jerry E. ;
Moldoveanu, Tudor ;
Llambi, Fabien ;
Parsons, Melissa J. ;
Green, Douglas R. .
MOLECULAR CELL, 2010, 37 (03) :299-310
[10]   Cell death: Critical control points [J].
Danial, NN ;
Korsmeyer, SJ .
CELL, 2004, 116 (02) :205-219